Literature DB >> 15972864

Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

Scott D Solomon1, Steve Zelenkofske, John J V McMurray, Peter V Finn, Eric Velazquez, George Ertl, Adam Harsanyi, Jean L Rouleau, Aldo Maggioni, Lars Kober, Harvey White, Frans Van de Werf, Karen Pieper, Robert M Califf, Marc A Pfeffer.   

Abstract

BACKGROUND: The risk of sudden death from cardiac causes is increased among survivors of acute myocardial infarction with reduced left ventricular systolic function. We assessed the risk and time course of sudden death in high-risk patients after myocardial infarction.
METHODS: We studied 14,609 patients with left ventricular dysfunction, heart failure, or both after myocardial infarction to assess the incidence and timing of sudden unexpected death or cardiac arrest with resuscitation in relation to the left ventricular ejection fraction.
RESULTS: Of 14,609 patients, 1067 (7 percent) had an event a median of 180 days after myocardial infarction: 903 died suddenly, and 164 were resuscitated after cardiac arrest. The risk was highest in the first 30 days after myocardial infarction--1.4 percent per month (95 percent confidence interval, 1.2 to 1.6 percent)--and decreased to 0.14 percent per month (95 percent confidence interval, 0.11 to 0.18 percent) after 2 years. Patients with a left ventricular ejection fraction of 30 percent or less were at highest risk in this early period (rate, 2.3 percent per month; 95 percent confidence interval, 1.8 to 2.8 percent). Nineteen percent of all sudden deaths or episodes of cardiac arrest with resuscitation occurred within the first 30 days after myocardial infarction, and 83 percent of all patients who died suddenly did so in the first 30 days after hospital discharge. Each decrease of 5 percentage points in the left ventricular ejection fraction was associated with a 21 percent adjusted increase in the risk of sudden death or cardiac arrest with resuscitation in the first 30 days.
CONCLUSIONS: The risk of sudden death is highest in the first 30 days after myocardial infarction among patients with left ventricular dysfunction, heart failure, or both. Thus, earlier implementation of strategies for preventing sudden death may be warranted in selected patients. Copyright 2005 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2005        PMID: 15972864     DOI: 10.1056/NEJMoa043938

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  186 in total

1.  Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial.

Authors:  Sana M Al-Khatib; Gail Hafley; Kerry L Lee; Alfred E Buxton
Journal:  Europace       Date:  2010-05-07       Impact factor: 5.214

2.  A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study.

Authors:  Colin J Petrie; Adriaan A Voors; Michele Robertson; Dirk J van Veldhuisen; Henry J Dargie
Journal:  Clin Res Cardiol       Date:  2011-09-21       Impact factor: 5.460

3.  Epidemiology and genetics of sudden cardiac death.

Authors:  Rajat Deo; Christine M Albert
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

4.  [ICD therapy for primary prevention. The patient in the early post-infarct phase].

Authors:  N C Ewertsen; G Steinbeck; J Senges; D Andresen
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

5.  Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design.

Authors:  Akihiko Shimizu; Takeshi Mitsuhashi; Takashi Nitta; Hideo Mitamura; Takashi Kurita; Haruhiko Abe; Yuji Nakazato; Naokata Sumitomo; Kazushige Kadota; Kazuo Kimura; Ken Okumura
Journal:  J Arrhythm       Date:  2014-09-12

6.  Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias.

Authors:  Dan Hu; Sami Viskin; Antonio Oliva; Jonathan M Cordeiro; Alejandra Guerchicoff; Guido D Pollevick; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

7.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Authors:  Nathaniel M Hawkins; Zhen Huang; Karen S Pieper; Scott D Solomon; Lars Kober; Eric J Velazquez; Karl Swedberg; Marc A Pfeffer; John J V McMurray; Aldo P Maggioni
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

8.  Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus.

Authors:  Brian S Moyers; Eric A Secemsky; Eric Vittinghoff; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue; Zian H Tseng
Journal:  Am J Cardiol       Date:  2014-01-16       Impact factor: 2.778

9.  Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction.

Authors:  Adrian Chrastina; Peter Pokreisz; Jan E Schnitzer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

10.  Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.

Authors:  Amy Leigh Miller; Kensey Gosch; Stacie L Daugherty; Saif Rathore; Pamela N Peterson; Eric D Peterson; P Michael Ho; Paul S Chan; David E Lanfear; John A Spertus; Tracy Y Wang
Journal:  Am Heart J       Date:  2013-09-05       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.